Randomised Controlled TrialtaVNSn = 12

Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19

Seitz T, Bergmayr F, Kitzberger R, Holbik J, Grieb A, Hind J, Lucny F, Tyercha A, Neuhold S, Krenn C, et al.

Frontiers in Physiology · 2023

Key finding

No side effects in aVNS were reported, especially no significant pain at device placement or during stimulation at the stimulation site or significant headache or bleeding after or during device placement or lasting skin irritation.

Condition
Long COVID
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
12
View on DOI

Cite this study

Seitz, T., Bergmayr, F., Kitzberger, R., Holbik, J., Grieb, A., Hind, J., Lucny, F., Tyercha, A., Neuhold, S., Krenn, C., Wenisch, C., Zoufaly, A., Kaniusas, E., & Széles, J. C. (2023). Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1223347

Related studies in Long COVID

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.